Ethicon’s Ablation System Gets Breakthrough Designation

August 4, 2020

The FDA has granted Johnson & Johnson subsidiary Ethicon a Breakthrough Device designation for its transbronchial microwave ablation technology with robotic-assisted bronchoscopy.

The designation pairs the NeuWave microwave ablation system with Auris Health’s Monarch platform, a robotic-assisted bronchoscopy system that provides improved access and control.

Ethicon said the combined technologies offer “an exciting opportunity to catalyze new approaches and solutions to improve patient outcomes.”

View today's stories